Clinical UM Guideline
Subject: Cataract Removal Surgery for Adults
Guideline #: CG-SURG-40 Publish Date: 09/27/2023
Status: Revised Last Review Date: 08/10/2023
Description

This document addresses cataract extraction in adults as a treatment for visually-significant cataracts, when lens removal is needed to allow better visualization of the retina or as a component of another surgical procedure. This document does not address congenital cataracts.

Note: Please see the following related topics for additional information:

Clinical Indications

Medically Necessary:

Cataract removal surgery in adults is considered medically necessary for any of the following:

  1. The lens displays signs of cataract formation and the following criteria are met:
    1. The cataract is causing symptomatic impairment of visual function not correctable with a tolerable change in glasses or contact lenses;
      and
    2. Vision loss interferes with one or more of the following:
      1. Reading; or
      2. Viewing television; or
      3. Driving, or
      4. Meeting vocational or recreational needs; or
      5. Other daily activities;
        and
    3. Other eye disease(s) have been ruled out as the primary cause of decreased visual function including, but not limited to:
      1. Macular degeneration; or
      2. Diabetic retinopathy;
        and
    4. Surgery is reasonably expected to result in improved visual function.
      or
  2. The individual has an underlying lens-related or other ophthalmologic disease for which cataract removal is indicated, including but not limited to the following:
    1. Phacomorphic glaucoma; or
    2. Phacolytic glaucoma; or
    3. Phacoanaphylactic endophthalmitis; or
    4. Dislocated or subluxated lens; or
    5. Angle closure glaucoma; or
    6. Elevated IOP associated with diagnosis of plateau iris configuration; or
    7. Uncontrolled pseudoexfoliation glaucoma;
      ​​​​​​​or
  3. Lens removal is needed for either of the following:
    1. To allow better visualization of the retina; or
    2. As a component of another surgical procedure, including, but not limited to the following:
      1. Diabetes with diabetic retinopathy requiring photocoagulation management through clear media; or
      2. To monitor progression of glaucoma where opaque media limits visualization of the optic nerve or visual field assessment; or
      3. Preparation for vitrectomy; or
      4. Preparation for surgical repair of retinal detachment.

Not Medically Necessary:

Cataract removal surgery in adults is considered not medically necessary when the criteria specified above are not met, or when either of the following apply:

  1. Glasses or visual aids provide satisfactory functional vision; or
  2. When the visual function is not compromised by the cataract.
Coding

The following codes for treatments and procedures applicable to this guideline are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.

When services may be Medically Necessary when criteria are met:

CPT

 

66830

Removal of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid) with corneo-scleral section, with or without iridectomy (iridocapsulotomy, iridocapsulectomy)

66840

Removal of lens material; aspiration technique, 1 or more stages

66850

Removal of lens material; phacofragmentation technique (mechanical or ultrasonic) (eg, phacoemulsification), with aspiration

66852

Removal of lens material; pars plana approach, with or without vitrectomy

66920

Removal of lens material; intracapsular

66940

Removal of lens material; extracapsular (other than 66840, 66850, 66852)

66982

Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; without endoscopic cyclophotocoagulation

66983

Intracapsular cataract extraction with insertion of intraocular lens prosthesis (1 stage procedure)

66984

Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation

66985

Insertion of intraocular lens prosthesis (secondary implant), not associated with concurrent cataract removal

66987

Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with endoscopic cyclophotocoagulation

66988

Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); with endoscopic cyclophotocoagulation

 

 

HCPCS

 

C1780

Lens, intraocular (new technology)

Q1004

New technology intraocular lens category 4 as defined in Federal Register notice

Q1005

New technology intraocular lens category 5 as defined in Federal Register notice

V2630

Anterior chamber intraocular lens

V2631

Iris supported intraocular lens

V2632

Posterior chamber intraocular lens

 

 

ICD-10 Procedure

 

08DJ3ZZ

Extraction of right lens, percutaneous approach

08DK3ZZ

Extraction of left lens, percutaneous approach

08RJ3JZ

Replacement of right lens with synthetic substitute, percutaneous approach

08RK3JZ

Replacement of left lens with synthetic substitute, percutaneous approach

 

 

ICD-10 Diagnosis

 

 

All diagnoses

When services are Not Medically Necessary:
For the procedure codes listed above when criteria are not met or for situations designated in the Clinical Indications section as not medically necessary.

Discussion/General Information

According to the Centers for Disease Control and Prevention (2015), cataracts are the leading cause of blindness and visual impairment, accounting for 50% of blindness representing 20.5 million (17.2%) Americans aged 40 and older. The Eye Diseases Prevalence Research Group estimates the number of individuals with cataracts is estimated to increase by 50% affecting nearly 30.1 million Americans by 2020, based on the U.S. Census population estimates (EDPRG, 2004).

Clouding of the lens of the eye is common in older persons and rarely seen in newborn children. This condition is generally known as "cataracts," but more specifically as age-related cataracts (also known as senile cataracts) or when present in previously unaffected adults, and as "congenital cataracts" when present in newborn infants. Other secondary cataracts include drug-induced cataracts and traumatic cataracts. The only available treatment for cataracts at this time is surgical removal of the cataract and replacement of the affected lens with a prosthetic lens. A variety of risk factors have been associated with cataract development. The most common risk factors include diabetes mellitus (DM), long-term corticosteroid (topical, systemic, intravitreal, inhaled or oral) use and history of prior intraocular surgeries (AAO, 2016).

The American Academy of Ophthalmology (AAO) issued guidelines for the use of cataract surgery in the adult eye in 2016, which states:

Evaluation of Visual Impairment

There is no single test or measure that adequately describes the effect of a cataract on a patient’s visual status or function ability. Similarly, no single test can properly define the threshold for performing cataract surgery. The Snellen visual acuity chart is an excellent tool for testing distance refractive error (e.g., myopia, hyperopia, astigmatism) in healthy eyes, and it is widely used clinically. Poor preoperative visual acuity correlates with significant postoperative functional improvement in many patients with cataract. However, testing only at distance with high-contrast letters viewed in low ambient lighting conditions underestimates the functional problems in common real-life situations. For example, reading (especially in poor-contrast environments), daytime or nighttime glare conditions, halos and starburst at night, and impaired optical quality causing monocular diplopia and ghosting are all important indicators. Because preoperative distance visual acuity alone may be an unreliable predictor of postoperative functional improvement, the decision to recommend cataract surgery should not be made solely on the basis of Snellen visual acuity.

Studies have indicated that measures of functional visual impairment provide valid and reliable information that is not reflected in the measurement of visual acuity alone. For example, visual function status indices such as the Activities of Daily Vision Scale (ADVS) and the Visual Function Index (VF-14) have been shown to better correlate with functional visual improvement after cataract surgery than measurement of Snellen visual acuity.

Cataract surgery should be recommended when indicated because of proven effectiveness in enhancing quality of life.

Indications for Surgery

The primary indication for surgery is visual function that no longer meets the patient’s needs and for which cataract surgery provides a reasonable likelihood of improved vision. Other indications for a cataract removal include the following:

Contraindications to Surgery

Surgery for a visually impairing cataract should not be performed under the following circumstances:

The extracapsular cataract extraction (ECCE) surgical procedure is used primarily for advanced cataracts where the lens is too dense to dissolve into fragments. This procedure involves the removal of the lens nucleus in one piece with an incision of approximately 10-14 mm, leaving the capsule in place. This technique provides added support and improves the healing ability of the eye. The most commonly performed type of ECCE surgery in the United States is phacoemulsification. Phacoemulsification, a form of extracapsular cataract extraction also called small incision surgery, softens and breaks apart the lens using ultrasound energy which is then aspirated from the eye through a smaller incision (2-4 mm). After the cataract surgery is completed a foldable plastic or silicone lens may be passed through the smaller incision. The advantage of phacoemulsification technique includes a more rapid visual recovery due to the small incision size. The small incision may self-seal or require 1-2 sutures, decreasing likelihood of suture-induced astigmatism.

The intracapsular cataract extraction (ICCE) surgical procedure is rarely performed in the United States. This technique involves the removal of the entire lens and surrounding capsule. It has a higher rate of complications when compared to ECCE.

A Cochrane review (Riaz, 2006) describes results from a meta-analysis of 17 trials involving 9627 individuals randomized for surgical interventions for age-related cataracts. The authors concluded that:

Phacoemulsification gives a better outcome than ECCE with a larger wound. We also found evidence that ECCE with a posterior chamber lens implant provides better visual outcome than ICCE with aphakic glasses. The long term effect of posterior capsular opacification (PCO) needs to be assessed in larger populations. The data also suggests that ICCE with an anterior chamber lens implant is an effective alternative to ICCE with aphakic glasses, with similar safety. Phacoemulsification provides the best visual outcomes but will only be accessible to the poorer countries if the cost of phacoemulsification and foldable IOLs decrease. Manual small incision cataract surgery provides early visual rehabilitation and comparable visual outcome to PHACO. It has better visual outcomes than ECCE and can be used in any clinic that is currently carrying out ECCE with IOL. Further research from developing regions are needed to compare the cost and longer term outcomes of these procedures e.g. PCO and corneal endothelial cell damage.

A retrospective study by Greenberg and colleagues (2011) reported on the prevalence and predictors of ocular complications associated with cataract removal in 45,082 participants undergoing care in the Veterans Health Administration (VHA) system. Diabetes mellitus (40.6%), chronic pulmonary disease (21.2%), age-related macular degeneration (14.4%), and diabetes with ophthalmic manifestations (14.0%) were the most common preoperative systemic and ocular comorbidities reported. Ocular complications most commonly reported among study participants included posterior capsular tear, anterior vitrectomy (or both) during surgery (3.5%) and posterior capsular opacification after surgery (4.2%). Identified predictors of complications included African-Americans, individuals who were either divorced or never married, DM with ophthalmic manifestations, traumatic cataract, and previous ocular surgery. The authors concluded, “Further large studies are warranted on the prevalence and predictors of ocular complications associated with cataract surgery for United States patient populations outside the VHA, including the role of factors such as resident training and surgeon volume.”

Definitions

Cataract: Cloudiness of the natural lens inside the eye which can blur vision.

Cornea: The clear, transparent cover over the iris and pupil on the front part of the eye. The cornea is the first part of the eye that bends (or refracts) the light and provides most of the focusing power of the eye.

Crystalline (natural) lens: The eye's natural lens that bends light (refracts) to provide some of the focusing power of the eye. The eye's natural lens is able to change shape allowing the eye to focus on different distances.

Glaucoma: A disease characterized by destruction of the nerve fiber layer of the optic disc.

Optic nerve: The nerve that carries images of what is seen from the eye to the brain.

Retina: The light-sensitive layer of tissue that lines the inside of the eye and sends visual messages through the optic nerve to the brain.

References

Peer Reviewed Publications:

  1. Gray CS, Karimova G, Hildreth AJ, et al. Recovery of visual and functional disability following cataract surgery in older people: Sunderland Cataract Study. J Cataract Refract Surg. 2006; 32:60-66.
  2. Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011; 118(3):507-514.
  3. Koo E, Chang JR, Agrón E, et al. Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33. Ophthalmic Epidemiol. 2013; 20(2):71-81.
  4. Lundstrom M, Barry P, Henry Y, et al. Evidence-based guidelines for cataract surgery: Guidelines based on data in the European Registry of quality outcomes for cataract and refractive surgery database. J Cataract Refract Surg. 2012; 38(6):1086-1093.
  5. Obstbaum SA, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, et al. Utilization, appropriate care, and quality of life for patients with cataracts. Ophthalmology. 2006; 113(10):1878-1882.
  6. Riaz Y, Mehta JS, Wormald R, et al. Surgical interventions for age-related cataract. Cochrane Database Syst Rev. 2006; (4):CD001323.

Government Agency, Medical Society, and Other Authoritative Publications:

  1. American Academy of Ophthalmology (AAO). Preferred Practice Patterns®: Cataract in the adult eye. Updated October 2016. For additional information: https://www.aao.org/guidelines-browse. Accessed on July 8, 2023.
  2. Centers for Medicare and Medicaid Services. National Coverage Determination. Phaco-Emulsification Procedure - Cataract extraction. NCD# 80.10. Available at: https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=9&ncdver=1&DocID=80.10&kq=true&SearchType=Advanced&bc=IAAAABAAAAAAAA%3d%3d&. Accessed on July 8, 2023.
  3. National Government Services, Inc. Jurisdiction J-K. Local Coverage Determination for cataract extraction (L33558). Revised 09/19/2019. Available at: https://www.cms.gov/medicare-coverage-database/new-search/. Accessed on July 8, 2023.
  4. Noridian Healthcare Solutions, LLC. Jurisdiction J-E. Local Coverage Determination for cataract surgery in adults (L34203) Revised 10/01/2019. Available at: https://www.cms.gov/medicare-coverage-database/new-search/. Accessed on July 8, 2023.
  5. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004; 122:477-485.
Websites for Additional Information
  1. American Academy of Ophthalmology. What are cataracts. Updated September 6, 2022. Available at: https://www.aao.org/eye-health/diseases/what-are-cataracts. Accessed on July 8, 2023.
  2. Centers for Disease Control and Prevention. Vision Health Initiative (VHI). Common eye disorders. June 03, 2020. Available at: http://www.cdc.gov/visionhealth/basics/ced/index.html. Accessed on July 2, 2022.
  3. MedlinePlus. Cataract. Updated May 7, 2018. Available at: http://www.nlm.nih.gov/medlineplus/cataract.html. Accessed on July 8, 2023.
  4. National Eye Institute (NEI). Cataracts. Updated January 13, 2023. Available at: https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/cataracts. Accessed on July 8, 2023.
  5. National Library of Medicine. Medical Encyclopedia: Cataract removal. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/002957.htm. Accessed on July 8, 2023.
  6. World Health Organization. Blindness and vision impairment. Updated October 13, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment. Accessed on July 8, 2023.
Index

Extracapsular cataract extraction (ECCE)
Intracapsular cataract extraction (ICCE)
Phacoemulsification

History

Status

Date

Action

Revised

08/10/2023

Medical Policy & Technology Assessment Committee (MPTAC) review. Revised formatting and hierarchy of Clinical Indications section. Updated References section.

Revised

08/11/2022

MPTAC review. In the Medically Necessary criteria, modified criterion related to vision loss (bullet A2). Updated the Description, References, and Websites for Additional Information sections.

Reviewed

08/12/2021

MPTAC review. Updated Definitions, References, and Websites sections.

Reviewed

08/13/2020

MPTAC review. Updated References and Websites sections. Reformatted Coding section.

 

12/31/2019

Updated Coding section with 01/01/2020 CPT changes; added 66987, 66988; revised descriptors for 66982, 66984.

Reviewed

08/22/2019

MPTAC review. Updated References and Websites sections.

Revised

09/13/2018

MPTAC review. Changed MN clinical indications for cataract removal surgery in adults with cataract formation, removed Snellen criteria and added criteria addressing functional impairment. Updated Description, References and Websites sections.

Reviewed

05/03/2018

MPTAC review. The document header wording updated from “Current Effective Date” to “Publish Date.” Updated Description, References and websites sections.

Reviewed

05/04/2017

MPTAC review. Updated formatting in Clinical Indications section. Updated Discussion, References and Websites sections.

Reviewed

05/05/2016

MPTAC review. Updated References and Websites sections. Removed ICD-9 codes from Coding section.

Reviewed

05/07/2015

MPTAC review. Description, References and Website sections updated.

New

05/15/2014

MPTAC review. Initial document development.


This Clinical UM Guideline is intended to provide assistance in interpreting Healthy Blue’s standard Medicaid benefit plan. When evaluating insurance coverage for the provision of medical care, federal, state and/or contractual requirements must be referenced, since these may limit or differ from the standard benefit plan. In the event of a conflict, the federal, state and/or contractual requirements for the applicable benefit plan coverage will govern. Healthy Blue reserves the right to modify its Policies and Guidelines as necessary and in accordance with legal and contractual requirements. This Clinical UM Guideline is provided for informational purposes. It does not constitute medical advice. Healthy Blue may also use tools and criteria developed by third parties, to assist us in administering health benefits. Healthy Blue’s Policies and Guidelines are intended to be used in accordance with the independent professional medical judgment of a qualified health care provider and do not constitute the practice of medicine or medical advice.

No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from the health plan.  
 
© CPT Only – American Medical Association